Dysport Receives FDA Approval - Stay Tuned!

Until last week, Botox Cosmetic was the only FDA approved Botulinum toxin A available as a wrinkle relaxer. Dysport (Reloxin), which has been used in Europe since 1991, was FDA approved in the United States last week. Physicians in the U.S. will be able to inject this product in a couple of months. The main question for patients and physicians is: How does it compare to Botox Cosmetic?

Unfortunately, as with most new products, there is literature to support claims of superiority of both products. The ultimate answer will come with time, as physicians in the U.S. gain experience with the product. Here are some early claims:

1. Dysport seems to spread more that Botox Cosmetic, which can be desirable on the forehead (requiring fewer injections), but undesirable near the eyebrows.
2. The dilution of each product is different, which may affect price.
3. You will undoubtedly see aggressive marketing promoting Dysport, because it is the latest FDA approved product. However, have a frank discussion with your physician to determine if their is truly an advantage to this product. I believe that with any new product or procedure, only time will tell.
   

We will strive to provide you with updated information as it becomes available. One thing is for sure: Competition is healthy, and there will be even better wrinkle relaxers in future years.

If you would like to inquire about Dysport, please call 239-594-9100 or visit our website, The Aesthetic Surgery Center in Naples.